The number of people with susceptibility test result for rifampicin in Saudi Arabia
Saudi Arabia: The number of people with susceptibility test result for rifampicin was 591 in 2021. ▼ Falling
Latest (2021)
591
Change on year
up 0.2%
World rank
77th
of 155 countries
All-time high
1,561
in 2018
All-time low
590
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Saudi Arabia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Saudi Arabia recorded 591 for the number of people with susceptibility test result for rifampicin in 2021.
The figure is up 0.2% on the previous year and down 42.4% over five years.
Saudi Arabia ranks 77th of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Saudi Arabia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 1,026 | — |
| 2018 | 1,561 | +52.1% |
| 2019 | 806 | -48.4% |
| 2020 | 590 | -26.8% |
| 2021 | 591 | +0.2% |
Saudi Arabia compared with similar countries
- Saudi Arabia's 591 is above the median for high income countries, which is 142, 4.2× the median. (61 countries reporting)
- Saudi Arabia's 591 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 406, 1.5× the median. (16 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1,131 | 806 | 1,561 | 3 |
| 2020s | 590.5 | 590 | 591 | 2 |
Countries ranked near Saudi Arabia
More health data for Saudi Arabia
- Un projection of annual infant deaths, annual growth rate -0.8373 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3736 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 483.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 829 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Population ages 00-04, female, annual growth rate 5.31 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0384 units per person (2025)
- Population ages 00-04, male, annual growth rate 5.38 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Saudi Arabia?
- The number of people with susceptibility test result for rifampicin in Saudi Arabia was 591 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Saudi Arabia?
- The highest recorded value was 1,561 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Saudi Arabia?
- The lowest recorded value was 590 in 2020.
- How does Saudi Arabia rank for the number of people with susceptibility test result for rifampicin?
- Saudi Arabia ranks 77th out of 155 countries with data for 2021.
- Where does this Saudi Arabia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).